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Congenital obstructive malformations of the ureter are
amongst the most common human birth defects. To date, the
etiology of these diseases has remained largely unexplored,
which has preempted any rational approach for therapeutic
intervention. Here, we describe that obstructive ureter
defects can arise from genetic insults affecting various
subprograms of ureter development including formation and
patterning of the ureteric bud, differentiation of tissue
compartments of the ureter, and junction formation with the
bladder and pelvis. New experimental findings have
highlighted the importance of epithelial–mesenchymal tissue
interactions in all of these subprograms and provided unique
insights into the molecular nature of the transcriptional
regulators and signaling pathways involved.
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The urinary system is a multicomponent entity, whose primary
functions are (1) the maintenance of body homoeostasis by
controlling the water and ionic balance of the blood, and (2)
the excretion of excess water, solutes, and waste products.
Anatomically, these functions are served by the composite
design of an upper unit comprised of the kidneys, which filter
and modify the blood, and a lower unit consisting of the
ureters, the bladder, and the urethra, which drain the urine to
the outside. The epithelial lining of the kidney is functionally
adapted to ensure the selective secretion and resorption of
solutes and water from the primary urine in renal tubules and
collecting ducts, while the urothelium constitutes a specialized
permeability barrier to urinary toxicity in the lower urinary
tract. The urothelium of the ureter and bladder is heavily
invested with smooth-muscle layers that provide structural
rigidity, flexibility, and contractility.
Rather than being a simple, passive tubular outlet of the
pelvis, the ureter represents a pivotal connection between the
upper and lower urinary systems. After filling the renal pelvis
with urine, the upper portion of the ureter undergoes
unidirectional peristaltic contractions, triggered by pacemaker
cells, to propel the urine down to the bladder, while preventing
any reflux or efflux at the same time. The specialized
anatomical design of the ureter interfaces with the pelvis and
the bladder as well as the two-layered tissue architecture of the
ureter tube itself ensure that these tasks are met.
The crucial importance of the ureter for renal function is
dramatically reflected by acquired and inherited defects that
interfere with the efficient removal of the urine from the
renal pelvis. Any kind of anatomical or functional obstruc-
tion along the ureter or at its junctions will result in fluid
pressure-mediated dilation of the tubular system proximal to
the side of constriction. Obstruction may originate from
physical barriers or compromised structural integrity and
peristaltic activity of the ureter. Dilation of the ureter
(hydroureter) will lead to dilation of the pelvis and collecting
duct system of the kidney (hydronephrosis). This condition
may progress to pressure-mediated destruction of the renal
parenchyme and culminate in end-stage renal disease.
Since congenital obstructive malformations of the ureter are
a leading cause of renal failure in children and young adults,1–3
analysis of the molecular pathways regulating normal ureter
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development are prerequisite to the identification of the genetic
aberrations underlying hydroureter/hydronephrosis and ex-
ploration of the disease etiology. In contrast to other organs
such as the kidneys, our knowledge of the genetic control of
ureterogenesis has been limited. However, recent experimental
findings from gene expression studies, embryological manip-
ulations, and particularly the phenotypic analysis of mouse
mutants (see Table 1 for an overview) have resulted in the
emergence of a more comprehensive picture of the genetic
circuits acting during ureter development. Here, we will review
the current status of ureter development by focusing on recent
molecular studies that highlight the importance of tissue
interactions for early ureter development and the etiology of
obstructive nephropathies.
URETER DEVELOPMENT
Although the ureter is structurally and functionally part of the
drainage system of the lower urinary tract, its ontogenetic
origin is clearly distinct from that of the bladder and the
urethra (see Figure 1, first four columns, for the embryonic
development of the ureter and its tissue compartments in the
mouse). While the latter two arise from the endodermal
urogenital sinus, ureters derive with the kidneys from the
Wolffian duct in the intermediate mesoderm. At embryonic
day (E)10.5 in mouse, an epithelial diverticulum called ureteric
bud (UB) evaginates from the distally elongating Wolffian duct
at the level of the hind limb buds and starts to grow toward an
adjacent group of mesenchymal cells. After intrusion into this
metanephric blastema, the tip of the UB acquires a drastically
different fate from the ‘stalk’—the portion remaining outside
of the metanephros. The tip engages in repetitive rounds of
elongation and branching and ultimately generates the
collecting duct system of the kidney, whereas the stalk merely
elongates to form the epithelial component of the ureter. From
E12.5 on, the distal end of the stalk separates from the
Wolffian duct and integrates into the developing bladder wall,
which establishes continuity of the urinary tract. Starting at
E15.5, the epithelium of the ureter stalk differentiates into the
urothelium, which is then able to resist the toxicity of the urine
being produced from E16.5 onwards. In parallel with the
dichotomy of epithelial development, mesenchymal cells
covering either region of the UB epithelium take completely
different developmental routes. The metanephric mesenchyme
surrounding the proximal tip regions undergoes a mesenchy-
mal–epithelial transition to form nephrons and differentiates
into interstitial mesenchyme or stroma, respectively. In
contrast, the mesenchyme surrounding the ureter stalk
differentiates into smooth-muscle cells that will form layers
with longitudinal and transverse orientation. Finally, the
establishment of the peristaltic machinery at the ureter–pelvis
junction, the pyeloureteric region, ensures full functionality of
the ureter at birth.
TAKING OFF: MESENCHYMAL CONTROL OF URETER BUDDING
Since formation of both ureter and metanephric kidney
depend on ureter budding from the Wolffian duct, any
disruption of this process will certainly have dramatic effects
on either structure. Both embryological manipulations and
genetic analyses have shown that the emergence of the
ureteric bud is not determined by positional information
intrinsic to the epithelial Wolffian duct, but that signals from
the adjacent mesenchyme direct the outgrowth, setting a first
paradigm for the importance of mesenchymal–epithelial
interaction for ureter (and kidney) development. Since the
regulation of ureter budding has been extensively reviewed in
recent years,36,37 we will summarize the key findings that are
relevant for ureter development. Temporal and spatial control
of ureter budding is achieved by establishment of a
mesenchymal signaling center at the posterior end of the
intermediate mesoderm at around E10.0, shortly before the
Wolffian duct has reached this position. Glial-derived
neurotrophic factor (Gdnf) released from the metanephric
blastema induces ureter budding and outgrowth from the
Wolffian duct. Loss of any of the components of the network
establishing and interpreting the Gdnf signal or the simple
experimental separation of the Wolffian duct from the
metanephric blastema disrupts or delays ureter budding
and outgrowth, leading to ureter and kidney agenesis in the
extreme and renal hypoplasia, or dysplasia in less severe cases.
Spatial restriction of Gdnf signaling is tightly controlled to
ensure the localized appearance of a single UB (Figure 1e).
Genetic ablation of the genes encoding the transcription
factors Foxc1 and Foxc2,7 and the signaling system of the
large secreted protein Slit2 and its receptor roundabout
homolog2 (Robo2)10 in the mesenchyme surrounding the
Wolffian duct results in the expansion of the metanephric
blastema and the region of Gdnf signaling. Ectopic activation
of the Gdnf signal transduction pathway is likely to be caused
by deletion of the signaling molecule bone morphogenetic
protein 4 (Bmp4)5,6 and the angiotensin type II receptor4 in
the mesenchyme surrounding the Wolffian duct, the cytosolic
factor Sprouty1,11 the adhesion molecule L1cam,8 and the
transcription factor Nfia9 in the Wolffian duct epithelium
(see Table 1, first section for a summary of mouse mutants
with obstructive ureter malformations caused by ectopic
ureter budding). Although it is still unclear how these
transcriptional activities and signaling pathways are precisely
interwoven to restrict Gdnf signaling spatially, phenotypic
analyses of some of these mouse mutants have established
that ectopic Gdnf signaling induces supernumerary ureteric
buds. These will give rise to additional kidneys and ureters
with improper connections to the bladder, leading to
hydroureter and subsequent hydronephrotic lesions due to
physical obstruction.4,6–8,10,11
PROXIMAL–DISTAL REGIONALIZATION OF THE URETERIC BUD
IS UNDER MESENCHYMAL CONTROL
Shortly after emerging from the Wolffian duct, the develop-
ment of the epithelium and its surrounding mesenchyme at
the two ends of the UB diverges. Which mechanisms direct
the proximal–distal segmentation of the UB into the kidney
and ureter? First, regionalization may rely on positional
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information acting independently and concomitantly in the
two tissue compartments. If this were the case, separation
and reverse recombination of mesenchyme and epithelium
should not affect the fate of either region. Alternatively, the
regional fate within one tissue compartment may depend on
prior specification of the other compartment. In this case, the
suggested transplantation experiments should result in fate
reversal. Indeed, the latter case seems to be close to the truth.
Tissue transplantation studies have demonstrated that proper
development and functional specification of ureter tissues
and other structures comprising the lower urinary tract
critically depend on epithelial–mesenchymal signaling. When
embryonic (E14.5) rat bladder mesenchyme is transplanted
onto adult proximal ureter, formation of a second bladder is
induced.38 This and other experiments39,40 indicate that the
mesenchyme controls the fate of the underlying epithelium,
and that the epithelial compartment possesses considerable
plasticity to respond to mesenchyme-derived instructive
Table 1 | Transgenic mouse models of obstructive ureter malformation
Gene Expression Nature of protein Genetic constitution Type of ureter malformation Ref.
Involved in specifying the budding site
Agtr2 um Angiotensin II receptor Agtr2/ Ectopic UB, duplex ureter, hydroureter 4
Bmp4 um Secreted bone
morphogenetic protein
Bmp4+/ Ectopic UB, duplex ureter, ectopic UVJ,
hydroureter
5,6
Foxc1(Mf1) um Forkhead transcription factor Foxc1/ Ectopic UB, duplex ureter, hydroureter 7
Foxc2 (Mfh1) um Forkhead transcription factor Foxc1+/,Foxc2+/ Ectopic UB, duplex ureter, hydroureter, ureter
agenesis
7
L1cam ue Adhesion molecule L1/y and L1+/ Ectopic UB, duplex ureter, megaureter,
hydronephrosis
8
Nfia ue, um Nuclear factor I transcription
factor
Nfia+/ and Nfia/ Duplex ureter, VUR, UPJ defects, hydro-ureter,
hydronephrosis, megaureter
9
Robo2 mm Slit2 receptor Robo2/ Ectopic UB, multiple ureters, hydroureter 10
Slit2 ue Robo2 ligand Slit2/ Ectopic UB, multiple ureters, hydroureter 10
Spry1 Wd, mm RTK/ERK antagonist Spry1/ Ectopic UB, multiple ureters, hydroureter 11
Spry2 Wd, mm RTK/ERK antagonist Pax2(4.0)HhSpry2, Wd, ue
overexpression
Ectopic UB, double ureter, hydroureter 12
Involved in ureter differentiation
Adamts1 um Secreted protease Adamts1/ Defective peristalsis, hydronephrosis 13
Bmp5 um Secreted bone
morphogenetic protein
short ear/ Hydroureter, hydronephrosis 14,15
Dlgh1 ue, um MAGUK scaffolding protein Dlgh1/ SM and stromal defects, short hydroureter,
hydronephrosis,ectopia of distal ureter ends
16,17
Foxd1 (BF2) um Forkhead transcription factor Foxd1/ Short ureter 18
Gata2 ue, um Zn-finger transcription factor Gata2/, YAC rescue Megaureter, hydroureter, hydronephrosis 19
Id2 ue, um bHLH DNA binding inhibitor Id2/ and Id2+/ UPJ defect, hydronephrosis 20
Shh ue Secreted Sonic hedgehog Hoxb7cre/+,Shhfloxed/floxed SM defects, short hydroureter, hydronephrosis 21
Smad4 ue, um TGFb-signaling effector Bmp7cre/+,Smad4floxed/floxed Hydroureter, hydronephrosis 22
Tbx18 um T-box transcription factor Tbx18/ Lack of SM, short hydroureter, hydronephrosis 23
Upk3a uro Transmembrane glycocalyx
component
Upk3a/ VUR, hydroureter, hydronephrosis 24
Upk2 uro Transmembrane glycocalyx
component
Upk2/ VUR, hydroureter, hydronephrosis 25
Involved in formation of junctional complexes
Ace Kidney Angiotensin I converting
enzyme
Ace/ Defective pyeloureteral peristalsis,
hydronephrosis
26
Agt Kidney Secreted angiotensinogen Agt/ Defective pyeloureteral peristalsis,
hydronephrosis
27,28
Agtr1a/1b um Angiotensin II receptor Agtr1a/,Agtr1b/ Hydroureter, pyeloureteral peristalsis, pelvis
agenesis
29
Calcineurin b um Protein phosphatase Calcineurin beta/ Defective pyeloureteral peristalsis,
hydronephrosis
30
Nfia ue, um Nuclear factor I transcription
factor
Nfia+/ and Nfia/ Duplex ureter, VUR, UPJ defects, hydroureter,
hydronephrosis, megaureter
9
Rara/Rarb2 ue (cnd) RA receptor/transcription
factor
Rara/,Rarb2/ Ectopia of distal ureter ends, hydroureter,
megaureter
31,32
Renin Kidney Enzyme, which generates
AngI from Agt
Renin/ Defective pyeloureteral peristalsis,
hydronephrosis
33
Ret Wd, ue Gdnf receptor Ret/ Ectopia of distal ureter ends 34
bHLH, basic helix-loop-helix; cnd, common nephric duct; Gdnf, glial cell derived neurotrophic factor; MAGUK, membrane-associated guanylate kinase; mm, metanephric
mesenchyme; RA, retinoic acid; RTK/ERK, cell receptor tyrosine kinase/extracellular signal-regulated kinase; SM, smooth muscle; ue, ureteric epithelium; um, ureteric
mesenchyme; UPJ, ureteropelvic junction; uro, urothelium; TGFb, transforming growth factor-b; UVJ, ureterovesicular junction; VUR, vesicoureteric reflux; Wd, Wolffian duct.
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signals. Recent studies have now provided novel insights into
the mesenchymal pathways underlying distalization of the
UB (Figure 1b).
We have recently shown that the T-box transcription
factor gene Tbx18 is expressed in a band of mesenchymal cells
located between the metanephric mesenchyme and the
Wolffian duct in E11.5 mouse embryos.23 At E12.5, Tbx18-
expressing cells are exclusively found at the distal ureteric
stalk (see Figure 1, third column, for ureteric expression of
Tbx18). Although genetic fate mapping of the E11.5 Tbx18-
positive cell population has not been performed, short-term
lineage tracing using a lacZ reporter integrated in the Tbx18
locus strongly argues that the ureteric mesenchyme is
specified shortly after ureter budding, which is long before
differentiation of the ureteric epithelium occurs.23 Several
papers, including a recent one by Brenner-Ananatharam
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et al.,41 have implicated the signaling molecule Bmp4 in
the specification and/or differentiation of the ureteric
mesenchyme and the distalization of the UB.6,41,42 Miyazaki
et al. have previously demonstrated that Bmp4 not only
prevents ectopic ureter budding from the Wolffian duct, but
is also involved in ureter development. Bmp4 is expressed in
the undifferentiated periureteric mesenchyme, and mice
heterozygous for a Bmp4-null allele exhibit hydroureter
probably as a result of smooth-muscle hypoplasia. In organ
culture experiments, Bmp4 promotes ureter growth as well as
aggregation of ureteric mesenchyme and subsequent differ-
entiation into smooth-muscle tissue.6,42 Brenner-Ananatharam
et al.41 have confirmed and substantiated the role of Bmp4 in
distal ureter-specific differentiation. Utilizing murine meta-
nephric kidney cultures, they have shown that Bmp4 is
required for ureter development, since smooth-muscle and
urothelial differentiation are severely impaired after condi-
tional inactivation of Bmp4. Bmp4 signaling in the
periureteric mesenchyme seems also to be responsible for
suppressing the morphogenetic program of the proximal UB
in the distal stalk region. Lowering the concentration of
active Bmp4 protein by application of recombinant protein
of the Bmp antagonist Gremlin1 to a kidney/ureter explant
system led to ectopic budding both from the Wolffian duct as
well as from the distal ureter stalk,43 confirming similar
findings from Bmp4 heterozygous mice.6 In a mouse explant
system, ectopic Bmp4 has proved to be sufficient to induce
smooth-muscle differentiation and urothelial differentiation
in domains of the UB normally fated to differentiate into the
intra-renal collecting system.41 Taken together, these findings
suggest that mesenchymal Bmp4 is both sufficient and
required to induce ureter development from the UB, which is
consistent with the notion that Bmp4 specifies the ureteric
mesenchyme.
In an alternative approach, Brenner-Amarantham et al.41
used cell labeling in the chick embryo to trace the lineage of
the mesenchyme surrounding the ureteric bud. They
confirmed that the metanephric mesenchyme derives from
intermediate mesoderm caudal to somite 28. Surprisingly,
lineage-tagged cells were not found in the mesenchyme
surrounding the ureter. Instead, labeling of mesodermal cells
from more caudal regions (designated ‘tail-bud’) resulted in
large populations of tagged cells appearing in the mesenchyme
surrounding the cloaca and the ureter. The tagged cells were
never contributing to nephrons, suggesting distinct origins of
the mesenchymal cells surrounding the proximal and distal
aspects of the ureteric bud. Intriguingly, the temporal and
spatial expression pattern of Bmp4 in chicks parallels the
movement of the tail bud-derived mesenchyme, which will
eventually engulf the epithelia of the entire lower urinary
system. These findings are highly significant, as they for the
first time provide evidence indicating that the mesenchymal
cells lining the lower urinary tract are developmentally
continuous and that Bmp4 is likely to be a common signal to
trigger smooth muscle differentiation, and possibly urothelial
differentiation throughout the lower urinary system. Clearly,
the lineage-tracing studies need to be confirmed and
extended to mammalian animal models, where tracing of
expression domains, such as that of Bmp4, is technically
feasible. Additionally, conditional tissue-specific inactivation
of Bmp4 at different time points is needed to stringently test
the roles of Bmp4 in the lower urinary tract.
It is presently unclear whether the Bmp4-expressing cell
population is a homogenous group of cells that is specified to
become ureteric mesenchyme at the time of migration, or
whether specification occurs later as a response to local cues.
It is tempting to favor the latter hypothesis, as the Bmp4
expression domain is subdivided into a domain that flanks
the metanephric blastema and expresses Tbx18, and a second
domain adjacent to the Wolffian duct, which is devoid of
Tbx18 (Figure 1h and j).23 Our molecular analysis has shown
that Bmp4 expression is unaltered in the urinary system of
Tbx18-deficient E11.5 embryos (unpublished observations).
However, expression of Bmp4 starts to decline at E12.5,
suggesting that Tbx18 maintains rather than establishes Bmp4
expression.23 Since Tbx18 expression has not been analyzed
in the urinary systems of Bmp4 mutant mice, the epistatic
relationship of Tbx18 and Bmp4 remains unknown. It
seems conceivable, however, that Bmp4 alone or in
combination with positively or negatively acting local signals
confers the spatially restricted Tbx18 expression, which will
define prospective ureteric mesenchymal cells. While the
metanephric mesenchyme has recently been excluded as a
signaling center required for ureter development,44 a source
Figure 1 | Embryonic development of the ureter in the mouse. Horizontal rows show successive stages characterized by important tissue
interactions from ureteric budding at E10.5 (a–e), specification of the ureteric mesenchyme at E11.5 (f–j), ureter elongation at E12.5 (k–o), onset
of tissue differentiation at E14.5 (p–t), and establishment of the periureteric peristaltic machinery at E18.5 (u–y). Vertical columns visualize
important features of ureter development with respect to the presence and interactions of different tissue compartments. Anterior is up in
the first three columns. (a, f, k, p, u) Morphology of isolated urogenital systems (UGS morphology). (b, g, l, q, v) Epithelium of the Wolffian
duct and its budding product the ureter (ue) as revealed by whole-mount in situ hybridization analysis for c-ret expression (b), and
b-galactosidase activity from a Pax2(8.0)::lacZ transgene specific for the Wolffian duct and its derivatives (g, l, q, v).35 (c, h, m, r, w) Ureteric
mesenchyme (um) as revealed by whole-mount in situ hybridization analysis for Tbx18 expression. Arrows in (c) indicate UGS expression of
Tbx18. (d, i, n, s, x) Ureter histology as revealed by haematoxylin–eosin staining of 5-mm transverse ureter sections. Rectangles indicate the
ureteric epithelium (orange) and the adjacent layer of mesenchyme (yellow). (e, j, o, t, y) Schemes of signaling pathways and tissue interactions
between the ureteric epithelium (orange) and the ureteric mesenchyme (yellow). Genes and factors are all mentioned in the text. Ellipses
indicate signals that are known to be relevant in ureter development; black arrows indicate secretion from or action on a tissue of a signal;
white arrows indicate processes mediated by a signal; dashed arrows indicate positive interactions between factors in a cell. Abbreviations: b,
bladder; E, embryonic day; k, kidney; mm, metanephric mesenchyme; SM, smooth muscle; te, testis; ub, ureteric bud; ue, ureteric epithelium;
um, ureteric mesenchyme; UGS, urogenital system; ut, ureteric tip; Wd, Wolffian duct.
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of such a local signal might be the Wolffian duct. More
generally, Bmp4 signaling in the lower urinary tract
mesenchyme may be translated into regional programs of
transcription factor activities that determine the distinct cell
fates found in the ureter, bladder, and urethra. In this respect,
Tbx18 misexpression experiments directed to the bladder
mesenchyme might answer the question whether Tbx18 is
sufficient to impose ureteric mesenchyme fate to the lower
urinary tract. In a comparable experimental setting in the
somitic mesoderm, Tbx18 was readily able to expand anterior
at the expense of posterior somite halves.45
Phenotypic analysis of Tbx18-mutant mice has shown that
prospective ureteric mesenchyme fails to condense and hence
disperses onto nearby tissues including the surface of the
kidneys.23 Therefore, the regulation of aggregation of
prospective periureteric cells might be an important function
of Tbx18. Separation of mesenchymal cell populations can be
achieved by selective adhesion or by repulsive interactions.
Although the existence of either mechanism has not yet been
experimentally tested, boundary formation between the
ureteric mesenchyme and the adjacent mesenchymal cell
populations is of great importance. Ultimately, it restricts the
extent of Bmp4 signaling and hence defines the proximal
boundary of the ureter program. As the expression of Tbx18
continues in condensed mesenchymal cells, it may be
required for maintaining borders at the points of intersection
with the kidney and bladder. Loss of coherence of these
mesenchymal cell populations could translate into defects of
the ureter junctions. In this respect, Tbx18 might not only
regulate the temporal duration of Bmp4 signaling, but also
limit its spatial spread. Additional control of Bmp4 signaling
may be provided by the gene encoding the Bmp agonist
Bmper (Cv2), whose expression has recently been detected in
the ureteric mesenchyme.46,47
Despite the exciting new insights gained by the analysis of
Tbx18 and Bmp4 functions in ureter formation, we have just
had a first glimpse of the molecular complexity involved in
early specification and differentiation of the ureteric
mesenchyme. To date, only a limited number of genes with
restricted expression in the ureteric mesenchyme have been
discovered. A role for Wnt signaling in ureter development
has been implicated based on the Tbx18-dependent expres-
sion of the Wnt-binding protein sFRP2 in the ureteric
mesenchyme.23 Furthermore, mouse mutants have suggested
additional roles for several transcription factors (see Table 1,
second section, for a list of mouse mutants with defects in
specification and maturation of the ureter). Gata2-deficient
mice have megaureter and severe hydroureternephrosis as a
result of obstructive ureter malformation.19 Expression of
Gata2, which occurs both in the epithelium and the
mesenchyme of the ureter, has precluded the assignment of
the primary function of Gata2 to one of the two compart-
ments. Interestingly, recent evidence suggests that Gata2 may
act as a direct target of Bmp signaling.48 Furthermore,
expression of Id2, which represents another candidate target
of Bmp signaling, is detected in the mesenchyme and later in
the smooth muscle layer of the ureter. Remarkably, Id2-
mutant mice (even in the heterozygous case) present with
hydronephrosis, which is possibly caused by increased
smooth-muscle proliferation in the pyeloureteric region.20
Taken together, analysis of the role of Bmp4-signaling and
Tbx18 transcriptional activity has provided decisive insight
into the molecular control of the specification of the ureteric
mesenchyme and its importance in directing distalization of
the UB. Failure to specify the ureteric mesenchyme will
compromise ureter development and lead to functional
obstructive malformation.
RECIPROCAL EPITHELIAL–MESENCHYMAL SIGNALING DRIVES
URETER MATURATION
With the completion of UB regionalization, a short ureter
tube with layers of undifferentiated epithelial and mesenchy-
mal cells has been established by E12.0. Maturation of this
simple tube is likely to be governed by reciprocal signaling
between the two tissue compartments (Figure 1o and t). The
crucial importance of epithelial signaling for further
mesenchymal development was recently demonstrated by
analysis of Sonic hedgehog (Shh)-mutant mice.21 Starting
from around E11.5, Shh expression is found in the ureteric
epithelium. Expression of the Shh receptor Patched1 in the
surrounding mesenchyme suggests a paracrine mode of
action. Indeed, tissue-specific ablation of Shh in Wolffian
duct derivatives leads to dramatic defects in the ureteric
mesenchyme. Smooth-muscle differentiation is delayed;
smooth muscle cells are less condensed and dramatically
reduced in number, explaining the severely hypoplastic
hydroureter phenotype of the mutant mice. Expression of
Bmp4 is completely lost in Shh-mutant ureters, suggesting
that Shh is required to maintain Bmp4 expression in the
ureteric mesenchyme. Since Bmp4 is a potent inducer of
mesenchymal cell aggregation and smooth-muscle differen-
tiation in vitro, loss of Bmp4 expression may explain the
smooth-muscle defects in Shh-deficient mice.6,21,49 Impor-
tantly, the Bmp4 requirement seems to be confined to a small
time window before E12.5, as the abolishment of Bmp4 at
later stages does not affect smooth-muscle differentiation in a
kidney/ureter explant culture system.41 Besides inducing
Bmp4 expression, Shh directly inhibits smooth-muscle
differentiation of ureter mesenchyme in vitro.21 This fact,
along with the finding that smooth-muscle differentiation,
which proceeds from proximal to distal, occurs only from
E14.5 onwards, therefore argues against a simple relationship
between Shh signaling, Bmp4 expression, and smooth-muscle
differentiation. Since Shh has a proliferative effect on ureteric
mesenchyme,21 Shh signaling might be required to enlarge
the pool of mesenchymal precursor cells before the onset of
smooth-muscle differentiation. Independent of whether
Bmp4 or other secreted factors induce smooth-muscle
differentiation, Bmp4 signaling seems to be tightly controlled
spatially and temporally. Tbx18-deficient ureters do no
longer express Ptch1, which may explain the failure to
maintain Bmp4 expression in the mesenchyme. Loss of Shh
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and Bmp4 signaling may therefore account for the defects in
ureter maturation, including lack of smooth muscle cells and
urothelial differentiation, observed in Tbx18-deficient mice.23
Interestingly, Tbx18 expression in the mesenchyme is lost at
the onset of smooth-muscle differentiation.23 A possible
requirement for Tbx18 in maintaining cells in an undiffer-
entiated proliferative state and in preventing terminal
differentiation may be tested by prolonged expression of
Tbx18 in ureteric mesenchyme. Similarly, Tbx18 expression is
also lost from mesenchymal condensations in the limb bud
mesoderm before the onset of chondrogenic differentiation.50
A further facet of the phenotype of Tbx18-deficient ureters
is the fact that the urothelium is not formed.23 This is
compatible with the notion that signals from smooth muscle
cells are required to induce and possibly maintain epithelial
differentiation of the urothelium. Although Bmp4 signaling
has been implicated in ureteric epithelial differentiation in
vitro, we believe that a direct inductive role of Bmp4 is
unlikely. As mentioned before, Bmp4 expression in the
ureteric mesenchyme precedes urothelial differentiation by
several days, arguing for additional mesenchymal signals
downstream of Bmp4. Impairment of urothelial differentia-
tion compromises ureter function, as shown by the hydro-
ureter phenotype of mice mutant for Uroplakin3a and
Uroplakin2.24,25 Uroplakins are a group of integral membrane
proteins that form two-dimensional crystals (urothelial
plaques) covering 90% of the apical urothelial surface.
Thus, differentiation defects in both mesenchymal and
epithelial ureter compartments result in functional obstruc-
tive nephropathy.
Ureter elongation requires tight coupling of the growth
and differentiation pathways acting in the mesenchymal and
epithelial compartments. Disruption of Shh expression in the
urinary system results in reduced proliferation of the
surrounding mesenchyme, causing organ-specific hypo-
plasia.21,51 The mitogenic activity of Shh in the ureteric
mesenchyme is independent of Bmp4, which rather appears
to act as an antiproliferative agent.21 Normal proliferation
rates in the periureteric mesenchyme are not maintained in
Tbx18-mutant ureters. This defect is most likely caused by
the downregulation of Patched1 and Shh signaling in the
mesenchyme. As a consequence, proliferation in the ureteric
epithelium is also severely reduced, leading to early cessation
of ureter elongation.23 The fact that two independent
molecular defects originating in different tissues present with
similar mutant phenotypes confirms the assumption that
reciprocal signaling between the epithelium and mesenchyme
is required for the coordination of ureter growth.
Recently, two interesting studies have implicated the
tumor suppressor gene disc large homologue 1 (Dlgh1) in
the cross-talk between the ureteric epithelium and mesenchy-
me.16,17 Dlgh1 is a member of the membrane-associated
guanylate kinase scaffolding proteins that contain three PSD-
95/Dlg/ZO-1 (PDZ) domains. Dlgh1 is expressed in both the
compartments of the ureter, although the expression levels
are significantly higher in the urothelium. Dlgh1 mutant mice
develop a short hydroureter and hydronephrosis at birth. The
mesenchymal compartment is severely disorganized, with a
lack of ureteric stromal cells. Furthermore, disorientation of
the circular smooth-muscle cells in a longitudinal direction
with subsequent defects in peristalsis is observed.16 Since the
formation and maintenance of the ureteric stromal cells,
which separate the smooth muscle from the urothelium,
depends on Shh signaling from the ureteric epithelium,21 it is
surprising that Shh signaling is normal in Dlgh1-deficient
ureters. Hence, Dlgh1 seems to play an important Shh-
independent function in the radial patterning of the ureteric
mesenchyme. Iizuka-Kogo et al.17 noted decreased prolifera-
tion in the ureteric epithelium of E12.5 Dlgh1-deficient
embryos, suggesting an additional cell or tissue-autonomous
function of Dlgh1.
Taken together, a number of reciprocal signaling systems
operate between the epithelial and mesenchymal tissue
compartment during ureter development, to coordinate
proliferation and differentiation in time and space. Disrup-
tion of these signaling systems will lead to disturbed ureter
elongation, tissue patterning, and differentiation that give
rise to functional ureter obstruction.
GETTING CONNECTED: SIGNALING FOR TUBULAR JUNCTIONS
While the maturation of the ureter tube requires tight
coordination between the epithelial and mesenchymal tissue
compartments, generating functional connections with the
proximal kidney and the distal bladder constitutes a me´nage a`
trois, if not a` quattre, that poses an even higher coordinative
challenge. The tasks are however clearly very different for the
two ends of the tube. At the proximal end, a continuous lumen
between the collecting duct system and the pelvis on one side
and the ureter on the other side is a mere consequence of their
common origin from the ureteric bud. However, formation of
the pyeloureteric peristaltic machinery is required to func-
tionally connect the ureter and the pelvis. This process is
initiated around birth and requires reciprocal interactions
between the urothelium and the pyeloureteric mesenchyme
(Figure 1y). The intracellular protein phosphatase calcineur-
inB1 is an important component in this tissue communication
process.30 Mice lacking calcineurinB1 in the ureteric mesenchyme
develop hydroureternephrosis due to smooth-muscle dyspla-
sia and subsequent lack of the pyeloureteric peristaltic
machinery. The mechanisms underlying this phenotype are
not known. One possibility is that calcineurinB1 mediates
angiotensin signaling, since disruption of either angiotensi-
nogen, the precursor of the angiotensin peptides; renin, the
enzyme generating angiotensin I from angiotensinogen; ace,
the enzyme generating angiotensin II from angiotensinogen;
or angiotensin II receptor all result in a similar phenotype.52
Alternatively, calcineurinB1 may be involved in the regulation
of Bmp signaling.
The situation is more delicate at the distal end of the
ureter, since the growing ureter has to be inserted into the
developing wall of the bladder to generate a valve-like
opening that ensures exit of the urine into the bladder but
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avoiding vesiculoureteric reflux. Recent findings suggest that
the transposition of the ureter from the Wolffian duct into
the bladder wall involves apoptosis of the common nephric
duct, the joint ending of the Wolffian duct and ureter.31
Analysis of Rara-, Rarb-, and c-ret-mutant mice has
implicated retinoic acid signaling originating from the
proximal bladder wall as a driving force in this process
during distal ureter maturation.31,32,34
Thus, failure to physically and functionally connect the
ureter to the bladder and renal pelvis are likely to arise from
defects in signaling between the tissues involved. Once again,
obstructive nephropathy will be at the end of developmental
anomalies concerning tissue interactions.
CONCLUDING REMARKS
The phenotypic characterization of an increasing number of
mouse mutants with urinary tract anomalies has brought the
ureter into the limelight by identifying it as a sophisticated
structural and functional component of the urinary system
that arises as the result of a delicate interplay of various cell
lineages during development. Disturbances of the communi-
cation between the principal cell lineages are likely to
underlie the anomalies of the ureter. Analysis of the origin
and fate of the cell lineages constituting the ureter,
identification and characterization of genes specifically
expressed in the various lineages, and detailed molecular
analysis of existing and newly generated mouse models will
undoubtedly provide a better picture of ureter development
in the future. At its best, analysis of the molecular program
governing ureterogenesis will provide a simple paradigm
for tissue interactions in vertebrate tubulogenesis. From a
clinical point of view, it will shed light on the etiology
of congenital obstructive nephropathy and open new
therapeutic avenues.
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